CoreAge Rx has launched new weight reset coaching and education programs, expanding its weight and metabolic health offerings. These programs aim to maximize patient success with affordable, doctor-guided GLP-1 medications like Semaglutide and Tirzepatide.
Research suggests that the GLP-1 drug tirzepatide, commonly used for weight loss, may also have the effect of boosting calorie-burning brown fat in the body. This finding could offer new insights into the drug's mechanisms of action.
A Mayo Clinic study indicates that postmenopausal women combining hormone therapy with the weight loss drug tirzepatide experienced 35% greater weight loss. Experts, however, advise caution regarding these preliminary findings.
Novo Nordisk's stock dropped significantly after new data showed its experimental weight-loss drug Cagrisema was less effective than Eli Lilly's tirzepatide.
CoreageRx has launched four new supplements aimed at muscle, digestion, and GLP-1 support, alongside advanced preventive longevity protocols. These new offerings include microdosing Semaglutide, Tirzepatide, and Sermorelin therapies.
A new pharmaceutical, apitegromab, is emerging as a potential alternative to preserve lean muscle mass during treatments involving drugs from the 'Ozempic family' like tirzepatide.
A study published in Nature identified a specific genetic variant that may enhance the effectiveness of GLP-1 weight-loss drugs such as semaglutide and tirzepatide.
A study led by the University of Barcelona demonstrates that the drug tirzepatide, in addition to controlling appetite, consumes calories by activating brown fat, revealing metabolic effects beyond just weight loss.
A London law student died in halls of residence after taking Tirzepatide, a weight loss drug prescribed as Zepbound in the US and Mounjaro in the UK, an inquest was told.
The National Bureau of Investigation (NBI) has arrested two individuals in Tondo, Manila, for allegedly selling P300,000 worth of an unregistered brand of tirzepatide, a weight-loss drug.
Recent advancements in semaglutide and tirzepatide-based medications have transformed obesity management, but genetic factors may explain why these weight loss injections yield better results for some individuals than others.